Tumor News and Research

RSS

NCRI CTRad publishes strategic priorities in radiotherapy research to improve patient outcomes

The NCRI Radiotherapy (CTRad) Group, a world-leading radiotherapy research group, has published its strategic priorities in radiotherapy research to address challenges in the field.

14 Jul 2022

Using microparticles to create 'self-boosting' vaccines

Most vaccines, from measles to Covid-19, require a series of multiple shots before the recipient is considered fully vaccinated.

13 Jul 2022

Mount Sinai receives $4.2 million to establish a Proteogenomic Data Analysis Center

The Office of Cancer Clinical Proteomics Research at the National Cancer Institute has awarded $4.2 million over five years to Mount Sinai researchers establishing a Proteogenomic Data Analysis Center to advance cancer research and treatments.

13 Jul 2022

Bioactive compounds in a marine sponge show potential to kill antibiotic-resistant bacteria

A research group led by scientists at the University of São Paulo (USP) in São Carlos, Brazil, has identified a number of bioactive compounds in a marine sponge collected on Fernando de Noronha, an archipelago about 400 km off the coast of Brazil's Northeast region.

13 Jul 2022

Researchers develop an AI system to classify IBD neoplasia lesions accurately

The incidence of inflammatory bowel disease (IBD) - an intractable disease characterized by chronic inflammation of the gastrointestinal (GI) tract - has increased significantly in Japan.

13 Jul 2022

New material for surgical dressings can be heated to kill melanoma cells but not other cells around it

Scientists from the University of Nottingham have combined graphene oxide, elastin, and ethanol to develop a new method to make this material conductive so it can be heated to kill melanoma cells but not other cells around it.

13 Jul 2022

Study reveals a specific metabolic adaptation in some patients with acute myeloid leukemia

An article published in the journal Nature Communications describes a specific metabolic adaptation in some patients with acute myeloid leukemia affected by tandem mutations in the FLT3 gene.

13 Jul 2022

New noninvasive method could allow screening for hypertension-linked aldosterone adenomas

Researchers have developed a noninvasive method to identify a potential cause of hypertension with a drastic reduction in radiation exposure, a study shows.

13 Jul 2022

How has the COVID-19 pandemic impacted prescribing pancreatic enzyme replacement to people with unresectable pancreatic cancer?

Researchers evaluated the impact of the COVID-19 pandemic on the rates of pancreatic enzyme replacement therapy (PERT) prescribing in England.

13 Jul 2022

Constant activation of p53 in hepatocytes of CLD patients could promote the development of liver cancer

p53 is one of the most important proteins in cancer biology. Often referred to as a "guardian of the genome," p53 becomes activated in response to various cellular stressors like DNA damage.

12 Jul 2022

Cancer cells can gravitate toward certain mechanical 'sweet spot' environments, study finds

An international team of researchers led by University of Minnesota Twin Cities engineers have found that cancer cells can gravitate toward certain mechanical "sweet spot" environments, providing new insights into how cancer invades the body.

12 Jul 2022

NCCN publishes new guidelines for treating pediatric CNS cancers

Today, the National Comprehensive Cancer Network published new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pediatric Central Nervous System Cancers.

12 Jul 2022

Study offers insight into cancer cell migration and opens new possibilities for stopping it

An international research group has investigated the mechanisms of cell migration and the impact of tissue rigidity on cell positioning and steering. The research sheds light on e.g. cancer cell migration and opens new possibilities for stopping and directing it.

12 Jul 2022

Network-based machine learning method helps predict cancer patients' response to immunotherapy

Immunotherapy is a new cancer treatment that activates the body's immune system to fight against cancer cells without using chemotherapy or radiotherapy.

12 Jul 2022

Activation of the STING pathway could help make glioblastoma multiforme more susceptible to immunotherapy

Immunotherapy has revolutionized treatment for many forms of cancer, but glioblastoma multiforme (GBM), the most common and deadly form of brain cancer, has remained untouched.

11 Jul 2022

Experimental model reveals possible causes and treatments for long-COVID

In a recent study published in the journal Science Translational Medicine, researchers characterized long-term pulmonary consequences of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) mouse-adapted strain (MA10) infection in BALB/c laboratory mice.

11 Jul 2022

Study sheds light on cell type-specific biomarkers of melanoma

A new UC Davis-led study sheds light on cell type-specific biomarkers, or signs, of melanoma. The research was recently published in the Journal of Investigative Dermatology.

10 Jul 2022

Clinical trial examining the combination of atezolizumab and chemoradiation for patients with limited-stage SCLC reaches accrual

The NRG Oncology/Alliance clinical trial NRG-LU005, examining the addition of the immunotherapy drug atezolizumab combined with chemoradiation for patients with limited-stage small cell lung cancer (SCLC) recently reached the trial's accrual goal of 506 patients.

8 Jul 2022

Study illustrates how the use of whole exome sequencing can better predict treatment response

Immunotherapies, such as immune checkpoint inhibitors, have transformed the treatment of advanced stage cancers.

8 Jul 2022

Moffitt researchers discover kidney cancer-specific splicing variant biomarkers

Kidney cancer accounts for only 4% of all cancers in the United States; however, its incidence has more than doubled since 1975, with the most common type being clear cell renal cell carcinoma.

8 Jul 2022

Tumor News and Research

NCRI CTRad publishes strategic priorities in radiotherapy research to improve patient outcomes

Using microparticles to create 'self-boosting' vaccines

Mount Sinai receives $4.2 million to establish a Proteogenomic Data Analysis Center

Bioactive compounds in a marine sponge show potential to kill antibiotic-resistant bacteria

Researchers develop an AI system to classify IBD neoplasia lesions accurately

New material for surgical dressings can be heated to kill melanoma cells but not other cells around it

Study reveals a specific metabolic adaptation in some patients with acute myeloid leukemia

New noninvasive method could allow screening for hypertension-linked aldosterone adenomas

How has the COVID-19 pandemic impacted prescribing pancreatic enzyme replacement to people with unresectable pancreatic cancer?

Constant activation of p53 in hepatocytes of CLD patients could promote the development of liver cancer

Cancer cells can gravitate toward certain mechanical 'sweet spot' environments, study finds

NCCN publishes new guidelines for treating pediatric CNS cancers

Study offers insight into cancer cell migration and opens new possibilities for stopping it

Network-based machine learning method helps predict cancer patients' response to immunotherapy

Activation of the STING pathway could help make glioblastoma multiforme more susceptible to immunotherapy

Experimental model reveals possible causes and treatments for long-COVID

Study sheds light on cell type-specific biomarkers of melanoma

Clinical trial examining the combination of atezolizumab and chemoradiation for patients with limited-stage SCLC reaches accrual

Study illustrates how the use of whole exome sequencing can better predict treatment response

Moffitt researchers discover kidney cancer-specific splicing variant biomarkers

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News